Users of medical cannabis in Connecticut can now be prescribed marijuana for otherwise untreatable headaches, severe rheumatoid arthritis, and Fibromyalgia, among other ailments under new rules approved this week.
The Regulations Review Committee of the state’s General Assembly approved updated Medical Marijuana Program regulations that added eight new conditions for which adults can use cannabis in the Nutmeg State. The new rules will also allow patients under 18 to use cannabis for Muscular Dystrophy and a condition called Osteogenesis Imperfecta when approved by a doctor, the Department of Consumer Protection announced Tuesday.
The six new conditions approved for medical cannabis use for adults were:
- Spasticity or Neuropathic Pain Associated with Fibromyalgia
- Severe Rheumatoid Arthritis
- Post Herpetic Neuralgia
- Hydrocephalus with Intractable Headache
- Intractable Headache Syndromes
- Neuropathic Facial Pain
“Now that these regulations have been accepted, more patients with severe medical conditions will have access to medical marijuana as a treatment option,” Connecticut Consumer Protection Commissioner Michelle H. Seagull said in a statement. “I want to thank our Board of Physicians and the committee for their thoughtful consideration of these conditions. I continue to be proud of the careful way that our program has expanded, and its commitment to a true medical model.”
Connecticut allows medical marijuana use for 30 conditions in all for adults, and eight for patients under 18. More than 27,300 patients are authorized to use cannabis, and nearly 1,000 doctors in the state can prescribe it.